Autoimmune conditions: warning signs, biomarkers and what to test

Genetic predisposition and HLA variants

The most significant known risk factor for many autoimmune conditions is genetic. Variants in HLA (human leukocyte antigen) genes, which govern how the immune system recognises self and non-self, are strongly associated with conditions including type 1 diabetes, rheumatoid arthritis, coeliac disease, Hashimoto's thyroiditis, and ankylosing spondylitis. However, HLA variants alone are not deterministic: many people carry autoimmune-associated variants without ever developing a condition. DNA testing can identify these genetic predispositions and contextualise whether your current biomarker pattern warrants closer monitoring.

Gut microbiome dysbiosis and intestinal permeability

The gut microbiome plays a central role in immune education, training white blood cells to distinguish between the body's own tissues and genuine threats. When microbiome diversity declines and the intestinal barrier becomes more permeable, a state associated with dysbiosis, bacterial products can enter the bloodstream and trigger immune activation patterns that may contribute to autoimmune processes. Research has identified specific microbiome compositions associated with rheumatoid arthritis, multiple sclerosis, and IBD. The gut-immune connection is particularly well established in coeliac disease, where gluten directly triggers autoimmune damage to the intestinal lining in genetically susceptible individuals.

Chronic stress and immune dysregulation

Sustained psychological stress alters the balance between pro- and anti-inflammatory immune activity. Cortisol, elevated during chronic stress, suppresses regulatory T cell function: the cells responsible for preventing the immune system from attacking self. When this regulatory layer is impaired, tolerance to self-antigens can break down, creating conditions that may trigger or accelerate autoimmune activation. Stress is consistently identified as a trigger for flares in established autoimmune conditions and is also implicated in initial onset in genetically susceptible individuals.

Sex hormones and why women are disproportionately affected

Approximately 75 to 80% of people with autoimmune conditions in the UK are women. Oestrogen plays an active role in modulating immune responses: it tends to upregulate humoral immunity (antibody production) while influencing regulatory T cell behaviour, making the immune system more reactive in ways that increase autoimmune susceptibility. Hormonal transitions, including puberty, pregnancy, the postpartum period, and perimenopause, are all associated with altered autoimmune risk windows. Understanding this pattern helps contextualise why symptoms in women are sometimes attributed to hormonal causes when autoimmune processes may be the primary driver.

Environmental triggers and molecular mimicry

Several environmental factors are associated with autoimmune onset. Specific viral infections, including Epstein-Barr virus (linked to multiple sclerosis and lupus), have been proposed to trigger autoimmune activation through molecular mimicry, where immune responses to the pathogen cross-react with structurally similar self-proteins. Smoking is a significant modifiable risk factor for rheumatoid arthritis, with a two to three times higher risk in smokers compared to non-smokers. Vitamin D deficiency is associated with higher rates of multiple autoimmune conditions, and repleting deficient levels is among the most practical modifiable risk factors.

Thyroid autoimmunity as a common early presentation

Hashimoto's thyroiditis is the most common autoimmune condition in the UK. It involves the production of antibodies, primarily anti-TPO (anti-thyroid peroxidase), that gradually damage the thyroid gland. Hashimoto's is often present for years, producing detectable antibodies and symptoms, before TSH shifts enough to register as abnormal on standard testing. It is also frequently the first autoimmune condition to develop in people who subsequently develop other autoimmune diseases, making it an important early indicator for broader autoimmune surveillance.

Standard autoimmune blood testing in the UK typically begins with an ANA (antinuclear antibody) screen, which detects antibodies directed against proteins within the cell nucleus. A positive ANA is not a diagnosis; it occurs in 5 to 15% of healthy people and requires interpretation alongside symptoms and more specific antibody tests. Where ANA is positive, further testing typically includes anti-dsDNA (specific to lupus), anti-Sm, anti-Ro, and anti-La antibodies.

For specific conditions, targeted antibody tests are more informative: anti-TPO for Hashimoto's thyroiditis, anti-tTG IgA for coeliac disease, rheumatoid factor (RF) and anti-CCP for rheumatoid arthritis. Inflammatory markers including CRP and ESR assess the degree of systemic inflammatory activity associated with autoimmune activation.

If you are experiencing symptoms that suggest an active autoimmune condition, particularly joint swelling, rashes in characteristic patterns, muscle weakness, or significant systemic illness, your GP should be the starting point for more targeted antibody testing and potential specialist referral. Home testing is most useful for people monitoring known thyroid autoimmunity, exploring early warning signs with a family history of autoimmune disease, or wanting to track inflammatory and nutritional markers alongside a known condition.

Vitamin D optimisation

Vitamin D has a regulatory role in immune function that is particularly relevant to autoimmune conditions: it supports the activity of regulatory T cells, which prevent the immune system from attacking self-tissues. People with autoimmune conditions consistently have lower vitamin D levels than matched controls, and vitamin D deficiency is associated with higher autoimmune disease activity in rheumatoid arthritis, multiple sclerosis, and lupus. Whether supplementation reduces disease activity alongside deficiency correction remains an active area of research, but maintaining optimal vitamin D status is supported by the available evidence and is low risk.

Gut health and the microbiome-immune axis

The gut microbiome trains immune cells and maintains the regulatory balance that prevents autoimmune activation. Supporting microbiome diversity through a diverse plant-rich diet, including 30 or more different plant species per week, reducing ultra-processed food intake, and including fermented foods, directly supports the immune regulation mechanisms most relevant to autoimmune risk. For people with coeliac disease or inflammatory bowel disease, managing the gut condition is inseparable from managing the autoimmune component.

Anti-inflammatory nutrition

A Mediterranean-style diet reduces the levels of pro-inflammatory cytokines associated with autoimmune flares and may slow disease progression in several autoimmune conditions. Omega-3 fatty acids from oily fish have specific anti-inflammatory effects relevant to autoimmune activity, reducing production of prostaglandins and leukotrienes that drive inflammation. Eliminating gluten is medically required for coeliac disease and is sometimes found helpful in people with other autoimmune conditions, though the evidence base outside coeliac is less definitive.

Stress management and HPA axis support

Because chronic stress impairs regulatory T cell function and can trigger autoimmune flares, consistent stress management practices are a meaningful component of autoimmune health. This includes sleep prioritisation (poor sleep is independently associated with higher inflammatory markers in autoimmune conditions), regular movement, and approaches that reduce sustained cortisol elevation. Tracking inflammatory biomarkers alongside intentional stress management gives measurable feedback on whether your approach is reducing systemic inflammatory load.